Global Postmenopausal Vaginal Atrophy Treatment Market Data Survey Report 2025
- HEY2158887
- 76 Pages
- October 2017
- Healthcare
Vaginal atrophy, also known as urogenital atrophy or atrophic vaginitis, is the inflammation of the vagina. It is the result of the vaginal tissues getting shrunken and thinned out. The most common cause of vaginal atrophy is the lack of estrogen, the female reproductive hormone. Vaginal atrophy can be caused during perimenopause and can get aggravated in the postmenopausal phase.
The global Postmenopausal Vaginal Atrophy Treatment market will reach Volume Million USD in 2017 with CAGR xx% 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
Allergan
Pfizer
Shionogi
Novo Nordisk
Teva Pharmaceutical
Bayer.
Major applications as follows:
Topical Estrogen
Systemic Estrogen
Non-hormonal Therapy
Regional market size, production data and export & import:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Global Market Overview
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 Regional Market
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 Key Manufacturers
3.1 Allergan
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Pfizer
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Shionogi
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Novo Nordisk
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Teva Pharmaceutical
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 Bayer.
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
4.1 Topical Estrogen
4.1.1 Overview
4.1.2 Topical Estrogen Market Size and Forecast
4.2 Systemic Estrogen
4.2.1 Overview
4.2.2 Systemic Estrogen Market Size and Forecast
4.3 Non-hormonal Therapy
4.3.1 Overview
4.3.2 Non-hormonal Therapy Market Size and Forecast
5 Market Price
5.1 Overview
5.2 Price by SUK
6 Conclusion
List Of Tables
Tab Regional Production 2011-2017 (Value)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Allergan
Tab Sales Revenue, Volume, Price, Cost and Margin of Pfizer
Tab Sales Revenue, Volume, Price, Cost and Margin of Shionogi
Tab Sales Revenue, Volume, Price, Cost and Margin of Novo Nordisk
Tab Sales Revenue, Volume, Price, Cost and Margin of Teva Pharmaceutical
Tab Sales Revenue, Volume, Price, Cost and Margin of Bayer.
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
List Of Figures
Fig Global Postmenopausal Vaginal Atrophy Treatment Market Size and CAGR 2011-2017 (Value)
Fig Global Postmenopausal Vaginal Atrophy Treatment Market Size and CAGR 2011-2017 (Volume)
Fig Global Postmenopausal Vaginal Atrophy Treatment Market Forecast and CAGR 2018-2025 (Value)
Fig Global Postmenopausal Vaginal Atrophy Treatment Market Forecast and CAGR 2018-2025 (Volume)
Fig Topical Estrogen Market Size and CAGR 2011-2017 (Value)
Fig Topical Estrogen Market Size and CAGR 2011-2017 (Volume)
Fig Topical Estrogen Market Forecast and CAGR 2018-2025 (Value)
Fig Topical Estrogen Market Forecast and CAGR 2018-2025 (Volume)
Fig Systemic Estrogen Market Size and CAGR 2011-2017 (Value)
Fig Systemic Estrogen Market Size and CAGR 2011-2017 (Volume)
Fig Systemic Estrogen Market Forecast and CAGR 2018-2025 (Value)
Fig Systemic Estrogen Market Forecast and CAGR 2018-2025 (Volume)
Fig Non-hormonal Therapy Market Size and CAGR 2011-2017 (Value)
Fig Non-hormonal Therapy Market Size and CAGR 2011-2017 (Volume)
Fig Non-hormonal Therapy Market Forecast and CAGR 2018-2025 (Value)
Fig Non-hormonal Therapy Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
